09Aug/13

Deals Of The Week: Isis Rethinks Its Partnering Strategy – The IN VIVO Blog (blog)


The IN VIVO Blog (blog)

Deals Of The Week: Isis Rethinks Its Partnering Strategy
The IN VIVO Blog (blog)
… arthritis drug Humira (adalimumab). The collaboration will involve biosimilar versions of four oncology drugs, including Roche/Genentech Inc.’s Rituxan (rituximab), Bristol-Myers Squibb Co./Eli Lilly & Co.’s Erbitux (cetuximab), Roche/Genentech’s …

09Aug/13

Physician Gave Chemo to Patients Without Cancer, Feds Say – Medscape


Medscape

Physician Gave Chemo to Patients Without Cancer, Feds Say
Medscape
For example, Dr. Fata would order 56 doses of rituximab (Rituxan, Genentech) over the course of 2 years for a patient with non-Hodgkin’s lymphoma compared with 12 doses that a “normal oncologist” might order. Dr. Fata Owned Firm That Did PET Scans, …
Oakland County cancer doctor accused of unnecessary treatments, defrauding …Detroit Free Press

all 53 news articles »

09Aug/13

Global Lung Cancer Therapeutics Market To Grow At A CAGR Of 13.26 Percent … – PR Newswire UK (press release)

Global Lung Cancer Therapeutics Market To Grow At A CAGR Of 13.26 Percent …
PR Newswire UK (press release)
Thus, the increase in the number of patients coming to China and India for cancer treatment is a growing trend, which is encouraging the healthcare organizations to opt for more lung cancer therapeutic drugs.” According to the report, one of the major …